Mobia Medical 3Q 2026: Revenue $15.62M, EPS ($0.52) — 10-Q Summary

Mobia Medical’s third-quarter revenue rose 73.3% year over year as adoption of its Vivistim System increased, while its net loss widened. Higher sales volume and lower inbound freight, tariff costs and inventory write-offs lifted gross margin; increased headcount, commercial activity and share-base…